Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1997 1
2000 1
2001 3
2002 1
2003 1
2006 4
2007 4
2008 5
2009 9
2010 7
2011 9
2012 9
2013 16
2014 9
2015 14
2016 11
2017 15
2018 19
2019 15
2020 13
2021 8
2022 12
2023 10
2024 14
2025 9

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

201 results

Results by year

Filters applied: . Clear all
Page 1
Longitudinal molecular profiling elucidates immunometabolism dynamics in breast cancer.
Wang K, Zerdes I, Johansson HJ, Sarhan D, Sun Y, Kanellis DC, Sifakis EG, Mezheyeuski A, Liu X, Loman N, Hedenfalk I, Bergh J, Bartek J, Hatschek T, Lehtiö J, Matikas A, Foukakis T. Wang K, et al. Among authors: lehtio j. Nat Commun. 2024 May 7;15(1):3837. doi: 10.1038/s41467-024-47932-y. Nat Commun. 2024. PMID: 38714665 Free PMC article.
Subcellular proteomics.
Christopher JA, Stadler C, Martin CE, Morgenstern M, Pan Y, Betsinger CN, Rattray DG, Mahdessian D, Gingras AC, Warscheid B, Lehtiö J, Cristea IM, Foster LJ, Emili A, Lilley KS. Christopher JA, et al. Among authors: lehtio j. Nat Rev Methods Primers. 2021;1:32. doi: 10.1038/s43586-021-00029-y. Epub 2021 Apr 29. Nat Rev Methods Primers. 2021. PMID: 34549195 Free PMC article.
FBXL12 degrades FANCD2 to regulate replication recovery and promote cancer cell survival under conditions of replication stress.
Brunner A, Li Q, Fisicaro S, Kourtesakis A, Viiliäinen J, Johansson HJ, Pandey V, Mayank AK, Lehtiö J, Wohlschlegel JA, Spruck C, Rantala JK, Orre LM, Sangfelt O. Brunner A, et al. Among authors: lehtio j. Mol Cell. 2023 Oct 19;83(20):3720-3739.e8. doi: 10.1016/j.molcel.2023.07.026. Epub 2023 Aug 16. Mol Cell. 2023. PMID: 37591242 Free PMC article.
Proteogenomics of non-small cell lung cancer reveals molecular subtypes associated with specific therapeutic targets and immune evasion mechanisms.
Lehtiö J, Arslan T, Siavelis I, Pan Y, Socciarelli F, Berkovska O, Umer HM, Mermelekas G, Pirmoradian M, Jönsson M, Brunnström H, Brustugun OT, Purohit KP, Cunningham R, Foroughi Asl H, Isaksson S, Arbajian E, Aine M, Karlsson A, Kotevska M, Gram Hansen C, Drageset Haakensen V, Helland Å, Tamborero D, Johansson HJ, Branca RM, Planck M, Staaf J, Orre LM. Lehtiö J, et al. Nat Cancer. 2021 Nov;2(11):1224-1242. doi: 10.1038/s43018-021-00259-9. Epub 2021 Nov 22. Nat Cancer. 2021. PMID: 34870237 Free PMC article.
Molecular Profiling Defines Three Subtypes of Synovial Sarcoma.
Chen Y, Su Y, Cao X, Siavelis I, Leo IR, Zeng J, Tsagkozis P, Hesla AC, Papakonstantinou A, Liu X, Huang WK, Zhao B, Haglund C, Ehnman M, Johansson H, Lin Y, Lehtiö J, Zhang Y, Larsson O, Li X, de Flon FH. Chen Y, et al. Among authors: lehtio j. Adv Sci (Weinh). 2024 Nov;11(41):e2404510. doi: 10.1002/advs.202404510. Epub 2024 Sep 10. Adv Sci (Weinh). 2024. PMID: 39257029 Free PMC article.
The pan-cancer proteome atlas, a mass spectrometry-based landscape for discovering tumor biology, biomarkers, and therapeutic targets.
Knol JC, Lyu M, Böttger F, Nunes Monteiro M, Pham TV, Rolfs F, Vallés-Martí A, Schelfhorst T, de Goeij-de Haas RR, Bijnsdorp IV, Wang S, Zhang F, A J, Westerman BA, Sitek B, Lehtiö J, Koster J, IJzermans JNM, van Laarhoven HWM, Bijlsma MF, Medema JP, Henneman AA, Piersma SR, Brakenhoff RH, Cloos J, Cordo' V, de Jong D, Kazemier G, Koppers-Lalic D, Labots M, Le Large TYS, Martens JWM, Meijerink JPP, Mumtaz M, Scheepbouwer C, Kibbelaar RE, Noske DP, Steenbergen RDM, van Grieken NCT, van Houdt W, Giovannetti E, van Leenders GJLH, Jonkers J, Liu T, Yan M, Zhan X, Guo T, Jimenez CR. Knol JC, et al. Among authors: lehtio j. Cancer Cell. 2025 May 27:S1535-6108(25)00212-0. doi: 10.1016/j.ccell.2025.05.003. Online ahead of print. Cancer Cell. 2025. PMID: 40446800
Cancer Core Europe: Leveraging Institutional Synergies to Advance Oncology Research and Care Globally.
Carmona J, Chavarria E, Donoghue K, von Gertten C, Oberrauch P, Pailler E, Scoazec G, Weijer R, Balmaña J, Brana I, Brunelli C, Delaloge S, Deloger M, Delpy P, Ernberg I, Fitzgerald RC, Garralda E, Lablans M, Lëhtio J, Lopez C, Fernández M, Miceli R, Nuciforo P, Perez-Lopez R, Provenzano E, Schmidt MK, Serrano C, Steeghs N, Tamborero D, Wirta V, Baird RD, Barker K, Barlesi F, Baumann M, Bergh J, de Braud F, Fizazi K, Fröhling S, Piris-Giménez A, Seamon K, Van der Heijden MS, Zwart W, Tabernero J. Carmona J, et al. Among authors: lehtio j. Cancer Discov. 2024 Jul 1;14(7):1147-1153. doi: 10.1158/2159-8290.CD-24-0377. Cancer Discov. 2024. PMID: 38870393
Impact of the ONCOBIOME network in cancer microbiome research.
Zitvogel L, Derosa L, Routy B, Loibl S, Heinzerling L, de Vries IJM, Engstrand L; ONCOBIOME Network; Segata N, Kroemer G. Zitvogel L, et al. Nat Med. 2025 Apr;31(4):1085-1098. doi: 10.1038/s41591-025-03608-8. Epub 2025 Apr 11. Nat Med. 2025. PMID: 40217075 Review.
Harnessing T cell exhaustion and trogocytosis to isolate patient-derived tumor-specific TCR.
Manfredi F, Stasi L, Buonanno S, Marzuttini F, Noviello M, Mastaglio S, Abbati D, Potenza A, Balestrieri C, Cianciotti BC, Tassi E, Feola S, Toffalori C, Punta M, Magnani Z, Camisa B, Tiziano E, Lupo-Stanghellini MT, Branca RM, Lehtiö J, Sikanen TM, Haapala MJ, Cerullo V, Casucci M, Vago L, Ciceri F, Bonini C, Ruggiero E. Manfredi F, et al. Among authors: lehtio j. Sci Adv. 2023 Dec;9(48):eadg8014. doi: 10.1126/sciadv.adg8014. Epub 2023 Dec 1. Sci Adv. 2023. PMID: 38039364 Free PMC article.
201 results